FDA-Food2026-10-20Class IIPROCESSING DEFECT

Cronus Pharma AnaSed Equine Injection recalled for product discoloration

Nationwide distributionFoodPet

What this means

Cronus Pharma is recalling one lot of AnaSed Equine Injection (xylazine 100 mg/mL), a sedative for horses, due to reports of product discoloration. The affected lot is C25110AV1 with an expiration date of November 2027. Discoloration may indicate a quality issue with the medication.

  • If you have lot C25110AV1 (expiration Nov 2027), stop using it and contact Cronus Pharma or your veterinarian
  • Check your inventory for the affected lot number and expiration date
  • Return unused vials to your supplier or veterinary distributor
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Due to market complaints pertaining to product discoloration.

Intended for
Pets
Illnesses reported
None reported
Sold states
US Nationwide.
Affected count
5,819 vials
Manufactured in
2 Tower Center Blvd, East Brunswick, New Jersey, United States
Products
AnaSed Equine Injection (xylazine injection) 100 mg/mL, Sedative, 50 mL, Manufactured for: Cronus Pharma LLC, East Brunswick, NJ 08816, Made in India, NDC 69043-043-05; NADA 140-442; For intravenous (IV) or intramuscular (IM) use in horses only.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=V-0004-2027

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering pet owners — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.